Romidepsin Plus CHOP vs CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)
J. Clin. Oncol 2021 Nov 29;[EPub Ahead of Print], E Bachy, V Camus, C Thieblemont, D Sibon, RO Casasnovas, L Ysebaert, G Damaj, S Guidez, GM Pica, WS Kim, ST Lim, M André, AM García-Sancho, MJ Penarrubia, PB Staber, J Trotman, A Hüttmann, V Stefoni, A Re, P Gaulard, MH Delfau-Larue, L de Leval, M Meignan, J Li, F Morschhauser, R DelarueFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.